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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma is a malignancy that occurs in the squamous epithelium in the 
nasopharynx region. Recurrent Nasopharyngeal carcinoma is defined as tumor recurrence after the complete 
remission. Patients with recurrent NPC may experience local, regional, or both failure, with or without distant 
metastases and can damage surrounding tissue. 
Objective: To improve early diagnosis, early treatment, and the level of long-term survival for patients with 
recurrent nasopharyngeal carcinoma 
Methods: This research method was a retrospective descriptive based on medical record data in patients with 
recurrent nasopharyngeal carcinoma at ORL-HNS outpatient clinic subdivision of Head Neck Surgery, RSHS, 
Bandung from 2017 to 2019. 
Result: In RSHS Bandung, there were 1727 patient NPC period 2017-2019. There were 135 recurrent 
nasopharyngeal carcinoma patients (7,8 %) consist of 96 male and 39 female, aged over 40 years as many as 
107 patients. More patients were found in T3-T4 (56%), N2-N3(56%), M0 (91%), stage III-IV (75%). The 
duration of the patient experienced a relapse after initial therapy was less than 24 months (52%). 
Conclusion: Characteristics of recurrent nasopharyngeal carcinoma most of them come with stage III-IV, T3-
T4 without distant metastases, with a recurrence within less than 24 months. There was 7,8% recurrent 
nasopharyngeal carcinoma patients 
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Nasopharyngeal carcinoma is a malignancy that occurs in the squamous 
epithelium in the nasopharyngeal region. Nasopharyngeal carcinoma is a malignancy 
that often occurs in the head and neck region, as well as cancers that are placed 
according to empirically after cervical cancer, breast cancer, and skin cancer [1,2]. 
Nasopharyngeal carcinoma incidence in Western countries is rare but mostly 
found in Eastern countries, such as China, Japan, and Singapore. The average 
worldwide prevalence of nasopharyngeal carcinoma is around 20 cases per 
100,000 population. The incidence of Nasopharyngeal Carcinoma in Indonesia 
is 12,000 new cases per year. In 2016, there were 493 NPC patients in RSHS 
Bandung and often patients come with an advanced stage [2, 3].  
Recurrent nasopharyngeal carcinoma is defined as tumor recurrence after 
complete remission with radiotherapy. Recurrent nasopharyngeal carcinoma 
arises in the nasopharyngeal mucosa. Patients with recurrent NPC mostly have a 
failure of local, regional, or both, with or without distant metastases, thus 
extensively recurrent tumors can damage surrounding tissue, especially in the 
spread of paranasopharyngeal involvement of the skull base [4, 5]. 
Based on previous studies that the clinical features of recurrent 
nasopharyngeal carcinoma are different from the primary nasopharyngeal 
carcinoma. Therefore, it is very important to improve early diagnosis, early 
treatment, and the level of long-term survival for patients with recurrent 
nasopharyngeal carcinoma [6].  
2. MATERIAL AND METHODS 
This research method is a retrospective descriptive based on medical 
This research method is a retrospective descriptive based on medical record 
data in patients with recurrent nasopharyngeal carcinoma based on inclusion 
and exclusion criteria. Inclusion criteria were all patients diagnosed with 
recurrent NPC at ORL-HNS outpatient clinic subdivision of Head Neck 
Surgery, RSHS, Bandung from 2017 to 2019. Exclusion criteria were 
incomplete medical records. 
 
3. RESULT  
There were 1727 patients during period 2017-2019 in Hasan Sadikin Hospital 
Bandung and around 7.8% recurrence NPC. Patients who were diagnosed with recurrent 
nasopharyngeal cancer in the outpatient clinic ORL-HNS oncology division at Hasan 
Sadikin Hospital Bandung, there were 135 patients from 2017-2019. Sufferers consisted 
of 71% men and 29% were women. Most patients were found at the age of more than 40 
years by 79% while those under the age of 40 were 21%. Each patient’s educational status 
was classified as primary school (40%), junior high school (24%), high school (19%), and 
bachelor's degree (17%). There were 36% of patients unemployed, 22% as private 
workers, 26% entrepreneur and 16% government employee. 
Table 2 shows that patients generally come in stages III-IV followed by 75% of 
patients who come in stage I-II as much as 25%. There are 135 recurrent nasopharyngeal 
carcinoma patients who came with T3-T4 tumors by 56% while the rest of T1-T2. Based 
on lymph node metastasis as much as 51% at N2-N3 and the remaining 49% at N0-N1. 
Most of the patients who come have M0 (91%) and the rest are M1 (9%). 
Patients who experienced recurrence for less than 24 months were 70 people (52%) 
and the rest occurred recurrence for more than 24 months were 65 people (48%). 
Chemotherapy in 45% of patients who come with Recurrent Nasopharyngeal 
Carcinoma, while 25% given radiotherapy and 30% did combination therapy. 
Table 1. Characteristics of Recurrent Nasopharyngeal Carcinoma Patients 
Characteristics 
Patients 
Amounts  % 
Sex   
   Male 96 71 
   Female 39 29 
Age   
   ≤40 28 21 
   ≥40 107 79 
Educational Status   
  Elementary school 53 40 
  Junior high school 37 24 
  Senior high school 25 19 
  Bachelor’s degree 20 17 
employment status   
  Unemployed 48 36 
  Private workers 30 22 
  Entrepreneur 35 26 
  Government employee 22 16 
Total 135 100 












T    
  T1-T2 59 44 
  T3-T4 76 56 
N    
  N0-N1 66 49 
  N2-N3 69 51 
M    
  M0 123 91 
  M1 12 9 
Stage   
  I-II 34 25 
  III-IV 101 75 
Interval to recurrence   
  ≤ 24 70 52 
  ≥ 24 65 48   
Therapy   
  Chemotherapy 61 45 
  Radiotherapy 34 25 
  Combination 40 30 
4. DISCUSSION 
Res Research on the characteristics of recurrent NPC is still less 
common than studies that focus on the prevention of recurrent NPC. 
Recurrence of NPC has become a failure of treatment for Nasopharyngeal 
Carcinoma [6]. 
In this study, the gender distribution among NPC cases showed 96 
males and 39 females yielding a 2.3:1 ratio. according to the study by Wang 
Lijun et.al regarding more nasopharyngeal carcinoma patients are male with 
a ratio of 4.2:1 [2, 7].  In Asia, NPC prevalence is much higher in male than 
in females [8]. Deviana et.al showed that the incidence of NPC is more 
prevalent in patients aged 40-49 years [9]. The incidence of NPC increased 
with age correspond with this study that NPC patients are over 40 years as 
many as 107 people. 
Galuh et.al Showed that the distribution of educational status in patients 
with recurrent NPC mostly in primary education as much as 86.6% [10]. 
These results are correspond with this study that the most recent patient 
educational status is elementary school which is 40%. This study shows that 
the most patients with NPC have jobs with a total of 87 people according to 
a study conducted by Deviana et.al with the number of patients who have 
jobs (62.5%) compared to those who do not have jobs (37.5%) [9]. 
The study about prognosis conducted in China found that 83.33% was 
stage III-IV, while stage I-II only 16.67% Stage III NPC is the stage most 
often found as a new case and recurrence case in an endemic area that 
highest NPC incidence (included Asia) [6]. Supporting examination for 
recurrence of NPC can be found by biopsy. Generally, patients who relapse 
was found in end-stage of the disease and has been accompanied by 
enlargement of the cervical lymph node (75.8%), damage at the base of the 
skull, intracranial invasion, and encephalopathy [6, 11]. 
The study found that in 52% of cases of recurrence of NPC has a range 
of fewer than 24 months since the last treatment of the primary carcinoma. 
The recurrence NPC reaches its peak in the 6-12 months after the first 
treatment ended and most were found about 2 years after treatment [6, 11]. 
The recurrence risk was reduced gradually between 5-10 years that found 
only about 14% of the total incidence, and less than 5% were found relapse 
after 10 years from the first treatment [6, 12]. 
Patients with recurrent NPC cases have an 82% risk classification of 
tumor (T) according to the T classification when first diagnosed [6].  In a 
study conducted by Xin Jia et.al more than 50% of recurrence cases were 
found in the T3-T4 classification, this is suitable with this study found that 
56% of recurrence cases were found in T3-T4 [6]. Patients with the 
recurrence NPC (73.5%) most of them found localized in the 
nasopharyngeal region and followed by lymph node metastases in the neck 
(21.7%), but these results are different from this study that found recurrence 
NPC patients with N2-N3 lymph node metastases about 51% [6, 13]. In a 
study conducted by Xin Jia.et.al  that 23 patients out of 351 patients who 
experienced a recurrence of NPC occurred distant metastasis and 43.5% 
experienced bone metastasis. The data of this study show that M0 (no distant 
metastases) occurred in 123 of 135 cases in recurrence NPC. Recurrence 
patients has more serious TNM classification than the previous TNM 
classification of primary Nasopharyngeal Carcinoma [6, 13]. 
The first-line therapy for recurrent NPC is chemotherapy with the drug 
of choice most commonly are cisplatin and gemcitabine [8]. The risk of 
recurrence after the use of radiotherapy is associated with clinical end-stage, 
advanced T classification (T3-T4) and greater tumor volume can reduce 
radiation sensitivity so that conventional radiotherapy doses are not enough 
to kill all cancer cells. Patients with recurrent NPC of T1-T2 is more 
effective with radiotherapy than T3-T4. Correspond with this study of 
patients found more in T3-T4 so that more patients were treated with 
chemotherapy (45%) than treated with radiotherapy [8, 14]. IMRT is used 
to prevent the dose insufficiency. The majority of NPC patients have a 
recurrence after systemic therapy (chemotherapy). In a study conducted by 
Leong et al, 41% of patients who underwent radiotherapy had a survival rate 
of 5 years longer than those without radiotherapy [15]. 
5. CONCLUSION 
Characteristics of recurrent nasopharyngeal carcinoma most of them 
come with stage III-IV, T3-T4 without distant metastases, with a recurrence 
within less than 24 months. There was 7,8% recurrent nasopharyngeal 
carcinoma patients. 
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